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Abstract 
The Eae2 region located on chromosome 15 in mice are known to influence the 
development of CIA. Experiments have showed that the Cia30 region in Eae2 have 
influence on the CIA development in mice from the B10.RIII strain which is susceptible 
to CIA. The Adamts12, which function still are unknown, are located in the Cia30 region. 
Adamts12 has not only been observed in elevated concentrations in arthritis patients 
compared to healthy individuals but have also been shown to bind and degrade COMP a 
matrix protein present in cartilage. 
In the light of these results the Adamts12 could be a potentially candidate gene for de 
development of arthritis.  
To examine if the Adamts12 has any influence on CIA development there was preformed 
sequencing and expression analyses on two mouse strains. The strains used were the 
susceptible strain B10.RIII and the congenic strain B10.RIIICia30 which have 
homozygous genes from the CIA resistant RIIIS/J strain in the Cia30 region.  
Neither the sequencing with the PCR technique or the expression analysis with real-time 
PCR method did succeed properly which suggest that the Adamts12 is expressed in very 
low concentrations. 
 
Abstrakt 
Det er vist at Eae2 regionen på kromosom 15 i mus har indflydelse på udviklingen af 
CIA. Eksperimenter har vist at Cia30 regionen der er en del af Eae2 regionen har 
indflydelse på CIA udviklingen i den modtagelige stamme B10.RIII. Adamts12, hvis 
funktion stadig er ukendt lokaliseres i Cia30 regionen. Adamts12 har udover at være 
fundet i eleverede koncentrationer hos gigt patienter sammenlignet med raske individer 
også vist sig at kunne binde samt degradere matrix proteinet COMP hvilket findes i 
brusk. 
På baggrund af disse resultater kunne det tænkes at Adamts12 var et potentielt kandidat 
gen for udvikling af gigt. 
For at undersøge om Adamts12 har nogen indflydelse på udvikling af CIA blev der udført 
sekvensering og ekspressions analyser på to muse stammer. Der blev brugt den 
modtagelige stamme B10.RIII og den kongene stamme B10.RIIICia30 der har 
homozygote gener fra den resistente stamme RIIIS/J i dens Cia30 region. 
Hverken sekvenseringen med PCR teknikken eller ekspressions analysen med real-time 
PCR metoden viste sig at virke optimalt hvilket tyder på at Adamts12 er udtrykt i meget 
lave koncentrationer. 
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Introduction 
 
The aim of this project is to acquire further knowledge about the gene regulation of CIA 
(collagen induced arthritis) which is the animal model of rheumatoid arthritis. Through 
earlier research there have been located regions on the mice genome which influence the 
development of CIA. This project will focus on the gene Adamts12 which is located in 
the region Cia30 which is a part of the Eae2 locus.  
The first objective in this project is to confirm that the Adamts12 gene in the inbred 
mouse strains B10.RIII and the congenic B10.RIII.Cia30 used in this project has a single 
nucleotide polymorphism (SNP) at 3806 bp (cDNA in Adamts12) and the potential 
presence of other single nucleotide polymorphisms in this gene.  
The congenic B10.RIII.Cia30 mice is created by intercrosses between inbred B10.RIII 
mice (susceptible to CIA) and inbred RIIIS/J mice (resistant to CIA) and then 
backcrossed for 10 generations to create a Cia30 locus from the arthritis resistant RIIIS/J 
strainB10.RIII background. 
The B10.RIII mice are susceptible to rheumatoid arthritis. The B10.RIII.Cia30 mice is 
not resistant to rheumatoid arthritis (this demands homozygous RIIIS/J genes in the 
whole Eae2 locus) but is less susceptible than B10.RIII and expected to be harder to 
induce with arthritis than the susceptible strain. This is accomplished by purifying RNA 
from spleens from both mouse strains, creating cDNA and primers, and then use the PCR 
(polymerase chain reaction) method. 
The second objective is to study the expression of the adamts12 gene in both mouse 
strains after immunization with collagen type II for 10 days and the use of real time PCR.  
 
Rheumatoid arthritis 
Rheumatoid arthritis is a chronic disease. The disease is caused by an inflammation in the 
synovial-lined joints (Grassi, et al 1998), see figure 1, and can lead to deformities of 
joints (Scutellari, et al 1998) and a premature death (Gabriel, 2003 and Scutellari, et al 
1998). It is not known why rheumatoid arthritis affects more woman than men and why 
patients have a shorter life span than expected compared to the healthy part of the 
population (Gabriel, 2003). Maradit-Kremers, 2005 found that rheumatoid arthritis 
patients have a statistically significant higher risk for cardiovascular death even when 
removing the normal cardiovascular risk and the risk from comorbidities (other diseases, 
smoking and high cholesterol count) (Maradit-Kremers, 2005). 
 
Rheumatoid arthritis can have varied courses but without treatment, there will be a 
progressive joint degradation (Agger, et al 2005). The disease affects approximately 1 % 
of the adult population in the U.S. (Scutellari, et al 1998) distributed in a 3:1 ratio 
between females and males (Janeway, et al 2005).  
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Rheumatoid arthritis disease normally affects joints in hands, feet, wrists, knees (Grassi, 
et al 1998) and joints of the shoulders and hip (Scutellari, et al 1998), and rarely affects 
joints in the outer ends of fingers, the sacroiliac (joint between sacrum and spine) and the 
lumbar spine (lower back), but all joints can be affected. Soft tissue, muscles and vessels 
can be affected to express a growth of subcutaneous or dermal nodules, see figure 2, 
causing weakness and atrophy in muscles and vasculitis (Scutellari, et al 1998).  
The degradation of joints is caused by an inflammation, mostly with macrophages and 
lymphocytes, in the synovial joint tissue and by neutrophil granulocytes in the synovial 
fluid (Agger, et al 2005). 
 
 
 
Figure 1: Drawing of 
joint affected by 
arthritis. The synovial 
fluid is filled with 
inflammatory cells 
which cause joint 
swelling; the synovial 
membrane is growing 
and invading the bone 
and cartilage which is 
worn down by this 
invading tissue 
(Cleveland clinic, 
2008). 
Figure 2: Photo 
of dermal 
nodules in hand 
of a 47 year old 
female which 
suffers from 
arthritis on 15 
year 
(Abouth.com, 
2008). 
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Cells and processes within the immune system important in rheumatoid arthritis 
An inflammation can start when circulating B-cells can bind to self-antigens released 
from damaged tissue which can promote activation of more auto reactive B-cells or by T-
cells with specific self-peptides (auto reactive T-cells) can bind to self-MHC complexes 
and can also cause a local inflammation either by damaging tissue directly or by 
activating macrophages. Self reactive lymphocytes exists in the normal naïve lymphocyte 
repertoire but is normally not activated and broken down. 
B-cells can bind to self-antigens in damaged tissue. The B-cells is then activated by T-
cells which also is specific for self-peptide.  
The activation of B-cells by the T-cells promotes the B-cells differentials into plasma 
cells. The Plasma cells secrets large amounts of antibodies against the self-antigen. This 
leads to, on the site of injured tissue, that the newly produced antibodies made by the 
plasma cells binds to the injured tissue and thereby initiating an inflammatory response 
which will cause more damage to the already injured tissue. B-cells will again bind to the 
self-antigens and thereby amplifying the self reaction circle (Janeway, 2005).   
 
Macrophages arise from monocytes which maturate in the bone marrow; they circulate in 
the blood stream for a couple of days and then settles in different tissue where they 
differentiate into macrophages. The primary function of monocytes and macrophages is 
to phagocyte and digest invading microorganisms and for the monocytes to present the 
digested antigens (Agger, 2005). 
 
Lymphocytes covers three groups of cells which all differentiate from lymphoid stem 
cells; NK-cells, B- and T- cells, where B-cells are found in two types (type 1 and 2) and 
can differentiate into immunoglobulin producing plasma cells. T-cells are also found in 
two types the normal T-cells and NKT-cells. Overall the B-cells produce antibodies and 
the T-cells regulate the B-cells antibody synthesis, increase phagocyte activity and can 
attack infected cells (e.g. virus infected cells) (Agger, 2005).  
 
NK-cells (natural killer) are a part of the innate immune system. They do not have T-celle 
receptors (TCR) or B-cell receptors (BCR) and there is no known marker. NK-cells have 
instead an adhesion molecule CD56 which is in general specific for NK-cells. These cells 
can destroy different tumor cells and cells infected by viruses or microorganisms. The 
recognition which is independent from any MHC complex and without any earlier 
confrontation with target cells depends solely on surface molecules expressed by the NK 
cell which reacts with specific structures on the target cell. The NK-cells carries receptors 
that when they react with MHC1 blocks the activating signal which prevents the target 
cell from being destroyed. So destruction of a target cell depends on a balance between 
activating and inhibiting signals. The NK-cells have an IL-2 receptor which induces 
proliferation and the cells killer activity (Agger, 2005). 
 
B-cells are matured in the bone marrow, they produce anti bodies and transport them too 
its surface where they are sustained and function as BCR. This BCR binds to the specific 
antigen which activates the clonal expansion phase of the B-cell which differentiates into 
anti body producing plasma cell. These B-cells are called type 2.  
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There is also a B-cell type 1, these pose the majority of B-cells in the abdominal cavity 
and lung membrane fluid. These cells are renewed by local cell proliferation and produce 
IgM (bacterial antibody). Recognition between the two types is identified by the different 
markers on the cells surface (Agger, 2005). 
 
T-cells are matured in thymus and have the TCR and CD3 as cell surface markers. T-cells 
are dependent on antigen presenting molecules MHC class 1 and MHC class 2 (major 
histoine complex class 1 and class 2). These MHC1 glycoprotein complexes are found on 
the surface of all cells with a nucleus. The MHC1 glycoprotein complex is bound to 
peptides under its synthesis and presents these on the surface. MHC1 presents not only 
peptides from infectious agents like parasites or viruses but also from the cells own 
synthesis products. The MHC2 glycoprotein complex is only present on immune cell 
producing and regulating cells as dendritic cells, macrophages and B-cells.  
These complexes inform the T-cells which alien macro molecules that are absorbed by 
phagocytic cells. T-cells with CD4 markers have MHC2 affinity and function as T-helper 
cells where cells with CD8 markers have MHC1 affinity and are cytotoxic T cells. The T-
helper cells activate and up regulate immune functions for example make B-cells 
differentiate into immunoglobulin secreting plasma cells.  
There are two groups of T-helper cells, TH1 and TH2. The cytotoxic T-cells TC destroys 
cells with the correct antigen peptide bound to a MHC1 complex. There exist T-cells with 
CD4 surface markers which functions as regulatory T-cells, TR, which function as an 
inhibitor on B- and T-cell activation (Agger, 2005).   
 
The NKT-cells are T-cells, they have TCR but they also have NK markers. They do not 
recognize MHC1 and MHC2 but CD1d which presents hydrophobic and lipid antigens. 
NKT-cells produce cytokines, especially IL-4. These cells primary function is to regulate 
the immune system through the cytokines (Agger, 2005). 
 
Neutrofile granulocytes are matured in the bone marrow and circulate in the blood stream 
for a few hours before entering tissue. They function as very active phagocytes (Agger, 
2005). 
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Diagnosis of rheumatoid arthritis 
There is no final laboratory test to confirm the diagnosis of rheumatoid arthritis but there 
are several other laboratory tests which can confirm the abnormalities that feature 
rheumatoid arthritis. These are measurements of erythrocyte sedimentation rate, acute 
phase proteins, plasma viscosity (Grassi, et al 1998) and antibody recognition of the 
rheumatoid factor (RF), the Fc-part of IgG (abnormal IgG is produces by lymphocytes in 
the synovial membrane and will react with normal IgM and IgG) (Agger, et al 2005). 
Measurement of erythrocyte sedimentation rate and C-reactive protein provides 
information of the acute phase response. Radiography (plain film) is used as a standard 
procedure to examine the anatomic changes in joints caused by rheumatoid arthritis 
(Grassi, et al 1998). 
 
The criteria used in classification of rheumatoid arthritis is as follows 
 
1: Morning stiffness in joints – for more than 1 hour. 
2: Tissue swelling (arthritis) around 3 or more joints. 
3: Swelling (arthritis) in wrist joints or in finger joints.  
4: Symmetric swelling of joints.  
5: Rheumatoid nodules.  
6: Present of high concentration of serum known as rheumatoid factor (RF) 
7: Bone changes in hand and wrist joints – observable with radiographic 
 
The criteria for diagnosis of rheumatoid arthritis is defined by the presence of minimum 4 
out of the 7 criteria and criteria 1 - 4 have had to be present for minimum 6 weeks 
(Arnett, et al 1988).  
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Cia30 in the Eae2 locus 
When working with rheumatoid arthritis the animal model CIA (Collagen Induced 
Arthritis) can be used. CIA is induced in mice by immunization with bovine collagen 
type II. The mouse strain B10.RIII which should be similar to the C57BL/6 which is one 
of the most common used mice in research is used as control and as background for the 
congenic mice. The B10.RIII is susceptible and can easily be induced to provoke 
development of arthritis. The RIIIS/J mouse is resistant to collagen induced arthritis.  
To investigate which loci and genes are involved in the formation and regulation of 
rheumatoid arthritis congenic mice are created through backcrosses and intercrosses and 
these mice are then immunized with collagen and then their course of disease is followed. 
From different crosses it can be decided which loci and genes are involved and how the 
disease severity is controlled (Karlsson, et al 2005).  
 
 
 
 
 
 
 
 
 
 
 
 
According to the inheritance of the 
RIIIS/J alleles in the Eae2 region and 
the sex of the mice resistance or 
sensitivity to CIA can be observed 
(Karlsson, et al 2005).  
 
Mice were protected from CIA when 
they had two alleles from RIIIS/J in the 
Eae2 locus and had a high disease score 
when they had heterozygous alleles in 
the same locus. This shows that the 
Eae2 locus is involved in the control of 
arthritis development.  
All mice with RIIIS/J homozygous alleles in the Eae2 region were resistant to CIA but 
females with heterozygote alleles in the region had high disease scores, see figure 3 
(Karlsson, et al 2005).  
 
RIIIS/J (aa) homozygous mice with a single congenic in the Eae2 locus developed CIA 
but had a low score compared to the B10.RIII (bb) homozygous and the heterozygous 
(ab), see figure 4 (Karlsson, et al 2005). These data show that the Eae2 region on mouse 
chromosome 15 is involved in the control of CIA. 
 
Figure 3: Score charts following female (A) 
and male (B) mice development of collagen 
induced arthritis over time. The scores are 
based on visible inflammation of joints, 
ranging from 1-15 points for each paw 
affected. There is given 5 points for each 
wrist or ankle and 1 point for each knuckle. 
The maximum score for each mouse are 60 
points. The mice are homo (aa) – and 
heterozygous (ab) for RIIIS/J genes in the 
Eae2 region and homozygous B10.RIII (bb) 
(Karlsson, et al 2005). 
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Figure 5: Schematic figure of the 
Eae2 region on chromosome 15 and 
the Cia loci residing within this 
region. The arrows show which loci 
there is interaction between in the 
Eae3/Cia5 region on chromosome 3 
(Karlsson, et al 2005). 
The development of CIA is linked to four regions in the Eae2 region, Cia26, Cia30, 
Cia31 and Cia32 (Karlsson, et al 2005).  
It was also found that CIA suppression originated from homozygous RIIIS/J alleles (aa- 
the resistant mouse) in the Cia30 region but only when Cia5 on chromosome 3 had 
homozygous B10.RIII alleles (bb), marked with circle in figure 4. If the mice had Cia5 
homo- or heterozygous RIIIS/J (aa or ab) alleles the mice were protected from disease 
(Karlsson, et al 2005), see figure 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The telomeric region of the Eae2 region Cia26 is interacting with the Cia30 region. If the 
Cia26 region has homozygous alleles and the Cia30 region has homozygous B10.RIII 
alleles this interaction will promote a severe disease development especially in female 
mice. The Cia30 region also interacts with genes in Cia5 on chromosome 3 and genes in 
Cia26, 31, 32 on chromosome 15, see figure 5, and influence the levels of CIA through 
these interactions (Karlsson, et al 2005).  
 
 
 
 
 
 
 
 
In mice the Adamts12 gene is present in the 
Cia30 region. The Cia30 region is placed 
between the D15Mit80 and D15Mit150 markers 
which range from 7812831 – 14163375 bp 
(MGI database: informatics.jax.org), see figure 
5, and the Adamts12 gene is located at 
11009756-11290402 bp (MGI database: 
informatics.jax.org). 
Figure 4: Arthritis score chart for 
disease development for mice homo 
(aa) – and heterozygous (ab) for 
RIIIS/J and homozygous B10.RIII 
(bb) in the Cia30 region and either 
homo (aa) – and heterozygous (ab) for 
RIIIS/J and homozygous B10.RIII 
(bb) in the Cia5 region on 
chromosome 3. The mice were 
protected from CIA if they had 
homozygous RIIIS/J genes in Cia5 or 
if the mice had homozygous RIIIS/J 
genes in the Cia30 region and 
homozygous B10.RIII genes in the 
Cia5 (Karlsson et al, 2005). 
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Figure 6: The 
relative level of 
Adamts12 
expression in knee 
synovium and 
cartilage in RA 
patients and in 
normal persons. 
The *** indicates 
significant 
difference p = 
0.001 (Liu, et al 
2006).   
 
A potential candidate gene: Adamts12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Real-time PCR has shown an increased expression of Adamts12 in the cartilage and the 
synovium in arthritis patients see figure 6. Liu et al also found that Adamts12 also have 
the ability to bind and degrade COMP (Liu, et al 2006).  
Adamts12 (human) is found in the synovium, cartilage and tendon (Liu, et al 2006) 
where COMP (Cartilage Oligomeric Matrix Protein) (from bovine and rat) is located only 
in cartilage (Hedbom, et al 1992).  
Månsson et al have observed elevated serum concentration of COMP in rapid erosive 
arthritis (Månsson, et al 1995).  
 
The finding of elevated blood serum concentrations of COMP (a protein which normally 
is not found other places than in cartilage (Hedbom, et al 1992) and which presence in 
blood reflects matrix repair (Saxne & Heinegård, unpublished observation)) in RA 
patients indicates that one effect of RA is a higher level of free COMP.  
It is well known that RA degenerate cartilage and bone. When it is also observed that 
patients with RA have elevated levels of Adamts12 in the cartilage and synovium 
compared to healthy individuals and that Adamts12 can bind to COMP and degrade this 
(Liu, et al 2006) then Adamts12 is therefore a potential candidate gene for rheumatoid 
arthritis. 
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Figure 7: The domain organization of the Adamts12 gene found 
by sequencing and structural analysis. The Adamts12 gene 
consist of a signal peptide forming a prodomain, a 
metalloprotease domain, a disintegrin-like domain = Cys-rich 
TSP1 domain, a spacer 1 domain, 3 TSP1 like repeats a spacer 2 
region and 4 TS repeats in the C-terminal end (Cal, et al 2001).  
Adamts12 
The Adamts12 obtained from fetal lung tissue was sequenced and consists of a signal 
peptide forming a prodomain, a metalloprotease domain, a disintegrin-like domain = Cys-
rich TSP1 domain, a spacer 1 domain, 3 TSP1 like repeats a spacer 2 region and 4 TS 
repeats in the C-terminal end, see figure 7. The function of this gene is still unknown 
(Cal, et al 2001). 
 
 
 
 
 
 
 
 
Liu et al 2006 found that Adamts7 (unpublished data) and Adamts12’s C-terminal 4 
TSP1 like repeats interact with the EGF-like domain in COMP in vivo. This was showed 
by a two-hybrid assay in yeast (Liu, et al 2006).  
It was also shown in vitro that the C-terminal polypeptide of Adamts12 binds to COMP. 
This was done by a GST pull-down assay where the EGF part of COMP was fused to 
GST an immobilized on glutathione-Sepharose beads an incubated with E. coli cell 
extracts containing Adamts12 (Liu, et al 2006).  
Adamts12 binding to COMP in mammalian cells was confirmed in a 
coimmunoprecipitation assay where there was used anti-COMP antiserum (Liu, et al 
2006).   
 
Adamts12’s COMP-degrading ability was also investigated and it was found that the 
protein had the ability to digest COMP into a large and 2 minor fragments in vitro and 
vivo. The digestion activity of Adamts12 in vitro is pH dependent and the presence of 
Zn2+ is essential with the highest activity observed at 2 mM ZnCl2. The presence of Mg
2+ 
and Ca2+ also affected the efficiency but was not essential. The optimal pH range is of 
physiological pH 7.5 and up to 9.5. There was no enzymatic activity at pH above 10.5 or 
below 6.5 (Liu, et al 2006).  
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SNP in Adamts12 
 
The Adamts12 gene is found in Mus musculus on chromosome 15 in the Cia30 region 
located at 10,994,786-11,275,432 bp. The gene is 4803 bp distributed on 25 exons.  
According to the database MGI (mouse genomic informatics: informatics.jax.org) there 
are two SNP (single nucleotide polymorphisms) in the Adamts12 gene between the 2 
mouse strains C57BL/6J = B10.III and RIIIS/J. The first, an A/G snp is located at 
11041771 bp in a non coding area which can have importance for the gene regulation or 
splicing of the gene. The other snp, also an A/G snp, is located at 11256189 bp in a 
coding region which gives an amino acid substitution. Both are shown below with their 
flanking sequences. 
 
The snp at 11041771 bp. 
TTTTCTTTCT TAAATTTAAT AACTCATTAG CTTCCATTTA TGCTGTGCAT AAACTTATAA 
GGCAGGGGTC TCTATTGTCT TCCCCGCTGC ATTGTGAGCT TGGGGCTAAC TGGCCTAGGA 
GCTTCCAGGC AGCTGTCCTA TCTTTGCCTA GCACCTCACA GCAGGAGTGT TGGTATTACA 
GATGCATGGC TTCCAGGGGC CTGATCCCGT TCATCAGTCT TGCATTGCAA GACTTTTACC 
TGCAGAGACA CGTCCAGCCC TTGCTCATAT TTTGATTCAG TTTGTGTAAC TGTGATGTAA 
R TATCCAGCAG TGACCCCACA TTTTCTCATT GTCTGCTGTC TGGTGCCGAA CACGTTTGCT 
CTGTTTTATT CACTTCAAGC GGTCTAGATC AAGTGATGTC TACCCGTATT CCAGGCCAAA 
AGTTCCAATC TTTGACTCTT TAATTCATAA AAGTTTAGGG GAAAATATTT GAAACTCTAA 
AAGCATTCTG ATCCTTACCA ATCTTTCAGG TTTACTCATT CATTTCTTCG TGTGTGCTCC 
GGAGCTCATG TCCACAGCGA TGATCAATGT GTGTAGTTAT TTCCTTGTTT ATTATCTACA 
R= A/G 
 
The snp at 11041771 bp in the non coding area can be involved in regulatory functions 
but its relevance so far unknown.  
 
The snp at 11256189 bp. 
ACAGTGACCA GCCTTTGAAC AAGGACAAAA GCAACTCTGT GATATGGAAT AAGATCGGGG 
TACCTGAACA TGATGCTCCC ATGGAGACGG ATGCAGAACT ACCACTTGGA CCTCCACCAA 
CATCTTATAT GGGGGAAGAG CCCTCATGGC CTCCCTTCAG TACAAAAATG GAAGGCTCAT 
TACCTGCCTG GTCCTTCAAA AATGAGACAC CCAGGGATGA TGGGATGATC GCTGAAAAAT 
CAAGGAAGAT TCCACTCCCT CTTGCAGGAG ACCACCATCC AGCAACCTCA GAGAAGTTAG 
R AAACCATGAC AAATTGGCAT TGCCAAATAC TACAAATCCA ACCCAAGGCT TTGGGCCTGT 
CCTGACTGAA GAAGATGCCT CCAATCTGAT TGCCGAGGGG TTTTTGCTAA ATGCTTCTGA 
TTACAAGCAT CTTATGAAGG ACCACAGCCC TGCATACTGG ATTGTTGGAA ACTGGAGTAA 
AGTAAGAGAT TTTATTTCCT GTCTTAGACC TGATTTTTTA TGAAAAATGT CATAACAAGC 
TTGAGAGGAA ATATCTATCA AAGGATGTAC TTTCTACCTG TGACATACTT AAGCTCCTTT 
R= A/G 
 
The second snp located in the coding region affects the final Adamts12 protein because 
of two different triplets gaa (in B10.III) and gga (in RIII: S/J) are translated to glutamic 
acid and glycine, respectively.Because the B10.RIII.Cia30 mouse is an offspring from 
the parental strains B10.III (susceptible) and RIIIS/J (resistant) the B10.RIII.Cia30 
congenes have homozygous RIIIS/J genes in the Cia30 region on a B10.RIII background. 
The strain is created by heterozygous backcrosses followed by intercrosses to obtain the 
RIIIS/J homozygous in the Cia30 region. The sequencing is done to confirm what is 
found in the databases and to find additional polymorphisms that are not found in the 
databases, because these mouse strains are not so common. The B10.RIII mouse is, 
however, very similar to C57BL/6 which is perhaps the most commonly used mouse 
strain (pers. Comm. Åsa Anderson, 2007).
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Synthesis of cDNA: 
B10.RIII and 
B10.RIII.Cia30 
 
Sequencing of 
cDNA and 
genomic DNA: 
B10.RIII and 
B10.RIII.Cia30 
 
Primer design and PCR on 
Adamts12 
Cloning of PCR products 
into TOPO-vectors 
Figure 8: Schematic overview of the work process and methods used for the sequencing part of this 
project. 
Purification of RNA 
from spleen: 
B10.RIII and 
B10.RIII.Cia30 
Method overview 
 
Sequencing of Adamts12 
The flowchart below, figure 8, shows a simple overview of sequencing process of 
Adamts12 in the B10.RIII and B10.RIII.Cia30. First RNA is purified from spleen from 
both mouse strains; second, cDNA is made from the RNA. Third primers are designed 
and there was run PCR and the PCR products are purified and cloned into TOPO-vectors 
which are sent to sequencing. 
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Synthesis of 
cDNA: B10.RIII 
and 
B10.RIII.Cia30 
Real time PCR: 
B10.RIII and 
B10.RIII.Cia30 
 
Immunized with type II 
collagen 
Primer design Adamts12 
Purification of 
RNA from wrists 
and ankle: 
B10.RIII and 
B10.RIII.Cia30 
3 male B10.RIII 
and 3 male 
B10.RIII.Cia30 
mice 
Figure 9: Schematic overview of the work process and methods used for the expression analysis in 
this project. 
Expression analysis of Adamts12 
The flowchart below, figure 9, represents a simple overview of expression analysis of 
Adamts12 in the B10.RIII and B10.RIII.Cia30. Six mice, three from each mice strain was 
immunized with type II bovine collagen and left for 10 days and then put down by CO2 in 
a gas chamber. Skin and muscle was removed from the ankles and wrists and the bones 
were stored in RNAlater. RNA was purified from the ankles and wrists bones from the 
mice and cDNA were made from the previously purified RNA. There were designed real 
time primers (and the house keeping gene HPRT was used as control) and there was run 
real time PCR with dilution curves, see appendix 3. Because dye used in real-time binds 
to double stranded DNA as the PCR product it is possible to follow the PCR 
quantitatively and thereby examine if the Adamts12 is up or down regulated in the 
susceptible B10.RIII mice compared to the B10.RIII.Cia30 mice. 
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Method 
The animal model CIA 
The mouse model worked with in this project is called CIA for collagen induced arthritis. 
The B10.RIII.Cia30 congenic mice are backcrossed for ten generations and then 
intercrossed to have homozygous RIIIS/J (marked as aa in genotyping) genes in the 
desired area Cia30 which range between markers D15Mit80 – D15Mit150 on a B10.RIII 
(marked as bb in genotyping) background.  
The B10.RIII.Cia30 mice are not immune to CIA as the RIIIS/J strain because 
B10.RIII.Cia30 is only RIIIS/J homozygous in the Cia30 region and immunity to CIA 
demands homozygous RIIIS/J genes in the whole Eae2 region (Karlsson, et al 2005) but 
they are harder to induce then the susceptible B10.RIII. 
The mice were immunized with bovine type II collagen to provoke rheumatoid arthritis. 
When immunizing, with bovine type II collagen (often from nose) is mixed with an 
emulsifier, oil, (100 µl IFA) which creates a fat vesicle encapsulating the collagen and 
releasing the collagen slowly. The collagen and IFA emulgate is injected just a couple of 
mm over the tail root. It is normal to boost the collagen inducement on day 35 but in this 
experiment the mice were put down after 10 days.  
There were used three male B10.RIII and three male B10.RIII.Cia30.  
The mice were put down in a gas chamber and had their neck broken afterwards. They 
were cut open to remove the spleen and their feet were skinned and cut of over the wrists 
and ankles. The bones were stored in RNAlater (Ambion) at 4°C and there was purified 
RNA and made cDNA from each mouse.  
 
RNA purification introduction 
Before RNA purification of spleen from B10.RIII was stored in RNAlater which saturate 
the cells and stabilizes the RNA. This way RNA can be stored for weeks without 
breaking down (Ambion, 2007). When purifying RNA it is important to inactivate all 
RNases in the sample and ensure no further contact with RNases. This is done with RLT 
buffer Qiagen and β-mercapto-ethanol which breaks S-S bonds in proteins. When 
separated from RNases RNA is quite stable (Kielberg et al, 2003).  
RNases are very stable, they can be boiled, machine washed and autoclaved. Therefore it 
is important to always use gloves, properly cleaned or one-time use tools and pure 
chemicals (Kielberg et al, 2003).  
After RNA purification, a quality control is made by measuring the purity of the sample. 
This is done by measuring the samples absorption at 260 nm and 280 nm in a UV-
spectrophotometer (Kielberg et al, 2003).  
Nucleic acids all have an absorbance maximum at 260 nm where other molecules for 
example proteins have an absorbance maximum at 280 nm (Kielberg et al, 2003).   
By measuring the absorbance ratio between 260 nm and 280 nm the purity of the sample 
is given. A ratio above 2.2 is chemically clean but ratios above 1.7 are normally 
acceptable (Kielberg et al, 2003). 
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RNA purification 
The RNA collected was prepared from the spleen, wrists and ankles. The mouse was put 
down by an animal keeper. The tissue/bones were stored in RNAlater (Ambion) in 4°C 
until preparation. 
 
There was used a rotor-stator for homogenization of tissue and bones. It was washed 
thorough in detergent, autoclaved water and 70% ethanol before use. For manual see 
appendix 2. 
 
 
Determination of RNA concentration 
Before freezing of RNA 5 µl was removed for concentration measurement. The 5 µl RNA 
was mixed with 95 µl H20 and the absorbance was measured at 260 nm. 
 
The RNA concentration was calculated by the equation below:  
[RNA] ng/µl = Absorbance (260 nm) · 40 (converting factor) · 20 (dilution factor) 
 
 
cDNA introduction 
Since it is difficult to work with RNA it is necessary to change the RNA to DNA. This 
DNA is a copy of the mRNA and referred to as complementary DNA e.g. cDNA. The 
reaction is made with an oligo (dT)-polynucleotide as a primer in the 3’-end where the 
polyA-tale is attached and the polymerase reverse transcriptase. This enzyme is capable 
at using RNA as a template when producing single stranded DNA (Kielberg et al, 2003). 
 
 
Creation of cDNA from the purified RNA 
For synthesis of cDNA the iScript TM cDNA synthesis kit from BioRad was used.  
 
- 4 µl 5x iScript Reaction Mix 
- 1 µl iScript Reverse Transcriptase 
- 1 µg RNA 
- Nuclease free H20 to a total volume of 20µl 
 
To calculate the right amount of purified RNA in µl for cDNA synthesis the following 
conversion was used:  
 
RNA µg/µl = [RNA] ng/µl / 1000 
 
RNA µl = 1 µg / RNA µg/µl 
 
The following PCR program was used: 5 min at 25 °C, 30 min at 42 °C, 5 min at 85 °C, 
∞ 4 °C. 
The PCR product was frozen at - 20 °C.  
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Primer design and PCR introduction 
A PCR is divided in 3 major steps which are denaturation, annealing and elongation, se 
figure 10 below. 
Factors affecting PCR reactions are primer designs, denaturation temperature, annealing 
temperature and elongation temperature.  
In PCR reactions there are used a set of primers for copying a sequence; a forward and a 
reverse primer. The primers have to have a certain length for being specific enough to 
only anneal at the template sequence but the possibility for self annealing and primer 
dimer formation increases also with primer length (Rybicki, 2001). The optimal primer 
length is between 17 and 28 bp (Kielberg et al, 2003, Primer-3, Rybicki, 2001).  
 
DNA has to be denatured so the primers can anneal to the single stranded DNA this is 
done at 91 - 97 °C. The melting point for DNA is normally higher than the temperatures 
used for denaturation but this temperature is lowered by adding buffers with ionic 
strength lower than 150mM NaCl to the PCR reaction (Rybicki, 2001).  
 
The annealing temperature can be calculated from Tm= 4 · (nG+nC) + 2 · (nA+nT) °C. The 
annealing temperature used should be approx.   5 °C lower than the lowest temperature 
decided for the primer set. If the annealing temperature, compared to the primers optimal 
Tm, is to low the primers will anneal less specific, this will appear as smear in the lanes 
on the gel. If the temperature is too high, again compared to the primers optimal Tm, the 
primers will not bind so well and the PCR product will be lower compared to product at 
optimal Tm (Rybicki, 2001). 
 
The Taq polymerase has a halvlife time of approx. 30 min at 95 °C. This actually means 
that there should not be performed more than 30 cycles with cycle start temperature at 95 
°C for 1 min. If working with a short template approximately 300 bp then denaturation 
temperature can be reduced to minimum 88 °C. To run as many cycles as possibly with 
Taq activity intact the denaturation time depends on the denaturation temperature and 
template length. An increase in denaturation temperature will reduce the denaturation 
time. For example denaturation for 1 min at 94 °C or 30 s, if the template sequence is 
short can be changed to 15 s at 96 °C (Rybicki, 2001).  
 
The elongation time depends on the template length. The elongation temperature is 
normally between 70 - 72 °C. The Taq polymerase has a specific activity at 37 °C but the 
elongation starts already at the annealing phase where the temperature is a lot lower than 
in the elongation phase and therefore the binding between the polymerase and the primer 
is rather stable. At 70 °C the activity is optimal and the polymerase is running at 100 
bases pr. s. (Rybicki, 2001).  
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Table 1: The primer sets used 
for the PCR reactions and real-
time PCR. The primers sets are 
marked with different colors set 
wise for an easy recognition in 
the cDNA sequence of 
adamts12, se appendix X. The 
primer sets 0 and 7 were run at 
genomic DNA instead of 
cDNA as the other set to get the 
whole sequence with both ends. 
The length of each PCR 
product is shown in the last 
column.  The primer sets 0 and 
7 are presented with capital 
letters due to the fact that the 
database presents genomic 
DNA in capital letters where 
cDNA is presented in small 
letters. The colors represent the 
respective sequences in 
appendix 1.   
Primer design 
The primer sets, in table 1 below, was designed by PrimerSelect. The primers were 
synthesized at MWG.  
 
 
 
 
Primer pairs Primers bp 
0F CCCCAAGGAAAATGTGTTAGC 681 
0R GGGGGAAGCGGAAAGTG  
1F Tgccacgggagacaaact 806 
1R agaatgagccgaaccacaacaatg  
2F aagcctctcccgacgttccataa 879 
2R ccagccatacaccacttcttctca  
3F Tgctgcagacgggactcg 659 
3R Attgccagctgccttgatttc  
4F gtgcgagggatataagggtgatgg 972 
4R aaggctgttgattgtgggagta  
5F gacaagacccggaaacccaacagt 1044 
5R tagcaaaaacccctcggcaatca  
6F gggcctgtcctgactgaagaagat 841 
6R Gcactgggctcgcactgatg  
7F gagggaggagagccagcagtcatt 794 
7R GGCCCCAGAGAACGAAACCATC  
RT-F CCCCTGGCTTTCACCATT 167 
RT-R Atgtactccttgctgcatttcg  
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PCR  
To prepare the primers for use there were adding the amount of autoclaved water 
specified by MWG to the crystallized primers. There were made 10 times dilution of 
primers for use in the PCR Mix, see below. The diluted primers were stored at – 20 °C 
and the undiluted primers were stored at - 80 °C. 
  
There was made 9 reaction sets and to each reaction set was made the following mix. 
 
- 50.0 µl H2O 
- 6.25 µl X10 Thermobuffer = PCR buffer 
- 0.63 µl dNTP 
- 1.7 µl Forward primer 
- 1.7 µl Reverse primer 
- 1.0 µl Taq polymerase 
- 3.0 µl cDNA  
 
There was used 22.0 µl mix with 3.0 µl cDNA so the total volume of each reaction tube 
was 25 µl. 
 
The PCR reaction was run at the following program 
 
95 °C · 3.0 min + 35 · (95 °C · 30 s. + 59 °C · 1.0 min + 72 °C · 1.0 min) + 72 °C · 7 min 
 
After the reaction the part of samples which was not loaded on a gel was frozen at -20 °C. 
 
Preparation of gel 
The PCR products were run at 80 V on a 1.5 % agarose gel to confirm the presence of the 
target PCR product. 
 
The gel was made from the following recipe: 
0.7 g Agarose 
50 ml TAE buffer 
1 drop of ethidiumbromide 
 
Agarose and TAE buffer was mixed and micro waved for a short period of time approx. 6 
· 20 s = 2 min.  
 
When running the gel the samples were mixed with 3 µl loading buffer to a total volume 
of 13 µl and there was used 10 µl of a 1kb DNA ladder from BioLabs (5.1 kbp, 4.1 kbp, 
3.1 kbp, 2.0 kbp, 1.6 kbp, 1.0 kbp, 506 bp, 396 bp, 344 bp and 298 bp) was used as a 
marker.  
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Real-time PCR 
The principle behind real-time PCR is to follow a PCR quantitatively and to compare 
expression levels (up- or down regulation) compared to a control e.g. a housekeeping 
gene which is known to be stably expressed. It is important that the gene which 
expression is investigated and the control gene are approximately the same length so both 
genes are finished copying at the same time in each cycle.  
Real-time PCR is based on the same principles as regular PCR including template DNA, 
two primers, dNTP’s and a polymerase while the reaction is run with temperature cycles. 
The SYBR is a fluorescence dye which binds to double stranded DNA and therefore it is 
possible to follow the PCR quantitative in each cycle.  
The primers used for the real-time PCR was the real-time primer set, see table 1 and 
appendix 3, and the housekeeping gene Hprt as a reference.  
 
The reaction mix was prepared as follows 
 
12.5 µl Power SYBR PCR Master Mix  
1 µl Forward primer (x10) 
1 µl Reverse primer (x10) 
0.5 µl cDNA 
10 µl water 
 
Quadruple samples were made for both the target gene and the reference gene Hprt (a 
housekeeping gene). There were made 6 samples one from each mouse; 3 B10.RIII and 3 
B10.RIII.Cia30 (6 * 4 samples) in addition a blind test with H20 instead of cDNA (four 
for each primer) was included and there was also made two dilution curves for each 
primer set (there was used the following cDNA concentrations 101, 102, 103 and 104).  
 
The real-time PCR reaction was run at the following program 
 
95 °C in 10 minutes to activate the AmpliTaq Gold polymerase and then  
(95 °C in 15 sec and 60 °C in 60 sec) x 40 
 
The manual is described in appendix 3. 
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Results 
 
Documentation of PCR for primer set 5 and real time primers (RT) in 
B10.RIII.Cia30 
The PCR reaction was made from the protocol described in the method. The gel is loaded 
as follows in table 2 below and the finished gel is shown below in figure 10. 
 
Lane 
1 
Lane 2 Lane 3 Lane 4 Lane 
5 
Lane 6 Lane 7 Lane 8 Lane 
9 
1 kb 
ladder 
P5 – 
B10.RIII 
RT – 
B10.RIII 
HPRT – 
B10.RIII 
P5 P5 –  
B10.RIII.Cia30 
RT – 
B10.RIII.Cia30 
HPRT – 
B10.RIII.Cia30 
P5 
1 kb 
ladder 
P6 – 
B10.RIII 
RT – 
B10.RIII 
HPRT – 
B10.RIII 
P6 P6 –  
B10.RIII.Cia30 
RT – 
B10.RIII.Cia30 
HPRT – 
B10.RIII.Cia30 
P6 
Table 2: Overview for loading of the gel in figure 10. The PCR was run at 59 °C with 
Vtotal = 25µl.  
 
 
 
 
As can be seen in figure 10 above, there is a very clear band in lane 6 (top); this band is 
the PCR product from prime set 5 at 1044bp in B10.RIII.Cia30, see table 1. This 
confirms that primer set 5 works on the Adamts12 in the B10.RIII.Cia30 mouse and that 
the Adamts12 gene is expressed. 
There is a weak band in lane 7 (bottom) at approximately 200 bp. This is a PCR product 
from the RT primers in B10.RIII.Cia30 which confirms that the RT primers (167 bp) 
work on the Adamts12 in the B10.RIII.Cia30 mouse but there is also some smear in that 
lane. 
There is also a very weak band in lane 6 bottom which is around 1050 bp which could be 
the expected 1044 bp band sequence 6 but there is also a lot of smear in that lane so it is 
Figur 10: Lane 1 top and bottom is the marker l 
kb ladder, lane 2 top is primer set 5 in B10.RIII, 
lane 3 top is the RT primer set in B10.RIII, lane 4 
top is HPRT in B10.RIII a positive control and 
lane 5 top is primer set 5 without cDNA a 
negative control. Lane 6 top is primer set 5 in 
B10.RIII.Cia30, lane 7 top is the RT primer set in 
B10.RIII.Cia30, lane 8 top is HPRT a positive 
control in B10.RIII.Cia30 and lane 9 top is 
primer set 5 without cDNA a negative control. 
Lane 2 bottom is primer set 6 in B10.RIII, lane 3 
bottom is the RT primer set in B10.RIII, lane 4 
bottom is HPRT a positive control and lane 5 
bottom is primer set 6 without cDNA a negative 
control. Lane 6 bottom is primer set 6 in 
B10.RIII.Cia30, lane 7 bottom is the RT primer 
set in B10.RIII.Cia30, lane 8 bottom is HPRT a 
positive control in B10.RIII.Cia30 and lane 9 
bottom is primer set 6 without cDNA a negative 
control. 10 µl 1 kb ladder was used, 3 µl loading 
buffer and 10 µl PCR products.  
 
1000 bp 
1000 bp 
298 bp 
298 bp 
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not safe to confirm the presence of this band. The smear in these lanes could be due to the 
annealing temperature is not optimal. 
The “bands” in the bottom of all lanes except lane 4 top, 6 top, lane 8 top, 4 bottom and 8 
bottom is excess primer which all lies a bit lower on the gel compared to the controls. 
 
 
Documentation of PCR for real time (RT) primer set in B10.RIII 
The PCR reaction is made from the protocol described in the method. The gel was loaded 
as follows; table 3 below and shown below in figure 11. 
Lane 1 Lane 2 Lane 3 Lane 4 Lane 5 Lane 6 Lane 7 Lane 8 Lane 9 
1 kb 
ladder 
P6 – 
B10.RIII 
RT – 
B10.RIII 
HPRT – 
B10.RIII 
0 P6 –  
B10.RIII 
RT – 
B10.RIII 
HPRT – 
B10.RIII 
0 
Table 3: Overview for gel loading in figure 11. The PCR was run at 60 °C with 
Vtotal=25µl.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In figure 11 above, there is a very weak bands approximately at 200 bp in lane 3 and 7. 
Both lanes shows the PCR product from the RT primer set in B10.RIII and therefore the 
usability of this primer set in Adamts12 in B10.RIII is confirmed. 
The “bands” in the bottom of all lanes except lane 4 and 8 is excess primer which all lies 
a bit lower on the gel compared to the controls. 
 
 
 
1000 bp 
Figure 11: Lane 1 is 1 kb ladder, lane 2 primer set 6 in B10.RIII, lane 3 is 
RT primer set in B10.RIII, lane 4 is HPRT a positive control, lane 5 is a 
negative control, lane 6 is primer set 6 in B10.RIII, lane 7 is the real RT set 
in B10.RIII, lane 8 is HPRT the positive control and lane 9 is a negative 
control. There was used 10 µl 1 kb ladder, 3 µl loading buffer and 10 µl PCR 
products.  
298 bp 
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Documentation for primer set 5 and 6 in B10.RIII 
The PCR reaction is made from the protocol in method but with the annealing 
temperature at 60 °C. The gel was loaded as follows in table 5 below. 
 
Lane 1 Lane 2 Lane 3 Lane 4 Lane 5 Lane 6 Lane 7 Lane 8 Lane 9 
1 kb 
ladder 
P5 – 
B10.RIII 
P6 – 
B10.RIII 
HPRT – 
B10.RIII 
0 P5 –  
B10.RIII 
P6 – 
B10.RIII 
HPRT – 
B10.RIII 
0 
Table 4: Overview for gel loading in figure 12. The PCR was run at 59.5 °C with 
Vtotal=25µl.  
 
 
 
 
 
 
 
 
 
In figure 12 above, there are weak bands in lanes 2, 3 and 7 at approximately 1050 and 
850 bp which is the PCR product from primer set 5 (1044 bp) and 6 (841 bp) in B10.RIII. 
This confirms that these primer set works in Adamts12 in B10.RIII. 
The “bands” in the bottom of all lanes except lane 4 and 8 is excess primer which all lies 
a bit lower on the gel compared to the controls. 
 
Real-time PCR 
It was not possible to obtain usable results from the expression analysis.
1000 bp 
286 bp 
Figure 12: Lane 1 is the 1 kb ladder, lane 2 is primer set 5 in B10.RIII, lane 3 is primer set 6 
in B10.RIII, lane 4 is HPRT a positive control, lane 5 is a negative control, lane 6 is primer 
set 5 in B10.RIII, lane 7 is primer set 6 in B10.RIII, lane 8 is HPRT the positive control and 
lane 9 is a negative control. There was used 10 µl 1 kb ladder, 3 µl loading buffer and 10 µl 
PCR products.  
 
 24
Discussion 
 
The cDNA of Adamts12 from mouse strain B10.RIII 4803 bp was divided in eight 
overlapping primer sets in order to sequence the gene to confirm the sequence given by 
the MGI database and to confirm the presence of the single nucleotide polymorphism at 
3806 bp between the mouse strains B10.RIII and the congenic B10.RIII.Cia30 strain. The 
cDNA sequence and primer sets are shown in appendix 1 and in table 1 respectively. To 
obtain end sequences genomic DNA was used when PCR was run with primer sets 0 and 
7.   
 
Unfortunately, the first 8 primer sets used did not work. PCR was run with annealing 
temperatures ranging from 54 – 64 °C without any results (not shown). The controls 
(housekeeping gene hprt) did work which confirms that the PCR did work (data not 
shown).  
 
New primer sets were constructed but again it was not possible run successful PCR with 
all primer sets. All primer sets binding possibilities were checked by the pc program 3-
primer (http://frodo.wi.mit.edu/) which compares C/G content, possibility for primer 
dimer formation and self annealing for the 17 primer sets and they were all acceptable. 
 
The primer sets worked on both mice strains in primer set 5, 6 and the RT to some 
degree; see figures 10, 11 and 12.  
None of these primers worked stably though. Also here was PCR’s run from 54 – 64 °C 
many times without any success before any bands were appeared clearly visibly. 
Obtained bands they were often so weak that they were hard to see visually and almost, if 
not, invisible on photos, even if all PCR product was loaded on the gel. Only exception is 
the band from primer set 5 in figure 10 lane 6 top. In addition there a PCR product was 
not always seen in all tubes even if the PCR primer mix was from the same mix. This 
could indicate that there was a very small amount of Adamts12 transcript present in the 
cDNA because of very low expression possibly so low that there virtually was no 
expression. 
This technical problem could perhaps have been solved by adding cDNA directly to the 
PCR primer mix and then distribute it to the PCR tubes instead of, as done in this project, 
adding the cDNA to the PCR tubes and then add the PCR primer mix.  
 
The smear which sometimes was seen in the lanes (e.g. figure 10 lane 6 and 7 bottom) 
could be due to the primers displaying annealing problems at the given temperature and 
should normally be adjusted by changing the annealing temperature (Rybicki, 2001) but 
since the only temperatures where the PCR annealing worked was between 59 °C and 60 
°C it was not possible to manipulate much with the temperature and then again the smear 
was only rarely present.  
The primer annealing problem could also be a result of improper DNA denaturation 
properly and manipulating with the denaturation temperature might have made a 
difference. Raising the denaturation temperature would have made the DNA denature if it 
did not denature properly at the 95 °C used in this project, which is hard to imagine. 
When raising the denaturation temperature the polymerases activity will work in a shorter 
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time period than at a lower temperature (Rybicki, 2001). This means that it is not possible 
to run as many cycles as at a lower denaturation temperature which will probably give a 
lower yield. This is important to take in account if there already is a low Adamts12 
concentration present. This can however quite easily be solved by performing multiplying 
PCR on the PCR product. 
 
To investigate if Adamts12 have any influence on the development of CIA an expression 
analysis was preformed with real-time PCR.  
Six male mice, three susceptible and three congenic, were immunized with bovine 
collagen type II to provoke CIA. The mice were left for 10 days and then put down. RNA 
was purified from the bones from ankles and wrists and made into cDNA.  
The real-time primers did was tested in a regular PCR to confirm that they worked, see 
figures 10 and 11. The real-time primers were though unstably as the primer sets 5 and 6 
as discussed above.  
There were not any usable results obtained from the real-time analysis and therefore no 
data shown in this rapport. Whether the absence of results was due to primer annealing 
problems, discussed above, or to absence of Adamts12 is not known.  
It was expected that the expression of Adamts12 was unregulated in the susceptible strain 
B10.RIII compared to the congenic strain B10.RIIICia30 because of the congenic strains 
homozygous RIIIS/J genes in the Cia30 region.  
 
Cal et al, 2001 found expression of Adamts12 when investigating different human tissues 
both fetal (brain, lung, liver and kidney) and adult (heart, brain, placenta, lung liver, 
muscle, pancreas, spleen, thymus, prostate, testis, ovary, intestine, colon and leukocytes) 
the only tissue expressing Adamts12 was fetal lung tissue. They used Northern blots 
containing poly(A)+ mRNAs prepared from the tissue samples mentioned above and 
hybridized with a 1.8 kb cDNA specific for Adamts12. The fetal lung tissue was the only 
sample where an 8 kb transcript was found there were no transcripts found in the other 
tissues.  
Because Adamts12 only was found in fetal lung tissue could this suggest that Adamts12 
could participate in some kind of tissue remodeling process which takes place under 
physiological conditions (Cal et al, 2001).  
It was also found that Adamts12 was expressed in tumor samples and cancer cell lines e. 
g. gastrointestinal, colorectal, renal, pancreatic tissues, HeLa and A549 lung carcinomas 
and also in Burkitt’s lymphoma (Cal, et al 2001).  
 
The observations made by Cal et al 2001 which found that Adamts12 is expressed only in 
fetal lung tissue could in some explain why it was so difficult obtain a PCR product with 
primer sets 1 – 6 and the RT primers on the employed cDNA which was derived from 
spleen (in regular PCR) and wrists and ankles (in real-time PCR). However this could not 
explain why the gene end primer sets 0 and 7 did not succeed because they were run on 
genomic DNA which should be present in all tissues. However this could just be due to 
the fact that the primers had problems annealing to the DNA and more cycles could 
perhaps have made a difference. It is important to notice that the possibility for 
replication errors rise when running more than 30 – 35 cycles.  
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Månsson et al, 1995 and Liu et al, 2006 both found that the expression of Adamts12 is 
higher in arthritis patients compared to controls (healthy people). The main difference 
between experiments described in Månsson et al, 1995, Liu et al, 2006 and Cal et al, 
2001 is that Cal et al, 2001 did their experiments on normal and carcinoma tissues where 
Månsson et al, 1995 and Liu et al, 2006 did their experiments on tissues collected from 
patients which have had arthritis for many years and had erosive arthritis.  
In this project the mice were immunized with bovine collagen type II to induce arthritis 
but only for 10 days. Normally when doing arthritis experiments with bovine collagen 
type II immunization the mice are immunized again on day 35 to boost the arthritis 
development (pers. Comm. Åsa Andersson, 2007). When the mice were put down there 
was not observed any signs of arthritis. Accordingly, the results presented here indicate 
that Adamts12 is induced by long term arthritis and that the mice in this experiment were 
put down to early for expression detection.  
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Appendix 
 
1: Adamts12 genomic and cDNA sequence with primers 
 
The numbers are not genome numbering but just for an easy overview. The genomic 
sequence with introns, primer sets 0 and 7 are from the Entrez database: ncbi.nlm.nih.gov 
and the cDNA sequence are from the MGI database: informatics.jax.org. 
 
First exon genomic DNA 
 
1  CATAACTCACTATTTGTAAGTACATTTCATCCTGTGTAAAGGAGATGGGGGGGGGGGCGT 
61 GTTGTCCTAGGAGCCTCTGACGGCTCTTACTCTAGTTTCTTCCTGGCCAGCTGTCTAGGG 
121 TCTCCCCTATTTGGCCCGCATGCCCAGGCTCTGAGCCCGGAGGGAGGAGCTTGAGGGAGG 
181 AGGGCGTCCCCAAGGAAAATGTGTTAGCTGGCTGGAGGCCTGTCGGGTGGGGAAGCAGAG 0F 
241 GGGTGGGGATCTGGGGTGGGCTGAGCCCCTTGGCTCTGACCCAGTCCATGCTCTGGCCCG 
301 CAGGAAGAAGAAGCTGTCAGCTCATTCACTCCCCTTTCAGGACAGGGAGAGAATAAAAGC 
361 TCTCTGGTCCCATCGGCTTCAAAAAGCCACTAGAGCCTCCTGGTCAGCTTGCGGGCCGCT 
421 CCCTTCCCATGCTTGGACCATGTTCTCGGGCGTCTTTCTGTGCGGACACAGGCGAGGACT 
481 GGATATCTGCAGCTGAGAGCTAAAACTTTTAAAACTTTTCTTCTCCCCAACAACTGAACC 
541 ATGCCATGTGCTCGGGGGAGCTGGCTGGCCAAGCTCTCGATCGTGGCTCAGCTTATTAAT 
601 TTTGGGGCTTTTTGCCACGGGAGACAAACTCAGCCCTGGCCGGTTCGCTTCCCAGACCCG 
661 AGGCAAGGTTAGTGGCTTTTCTTTATTTGTTTTTCTAACAGTGGAGTAGGACAGTGGAAC 
701 TTGGTCTGTTCCCTTCCCCCACCAGGCAGGGCTGAACTCTAAGCCTTCTGGCCTGTCTAA 
721 GGAAAACTGCTGTGTGCTCAGGCTCGGATTTCCTTCTCTCCTAGGGCTTAAGGGTGCACA 
781 CTCAGGGGTGACACCCTGCTTGGAAAGACCCAAGAGTACGCTCGCTCCCCGAGCCCCTCC 
841 CCTCCACTTTCCGCTTCCCCCCTTTGCAGACTGTGACATGGGAAATTATTTTTAATAAAG 0R 
901 AGACCCAGCTGGTCACGGACAGTCATGGCAAATGTTTCCTTCATTTAAAACTTCATTTTA 
961 AGTCTGGAAGGTAGAAATTTTATTCTGGCCTCCTGCTGAGCACACTTGGCTGTGTTTTGG 
1021 TTTCCTGGAAAGATTTAGGGTTTTGTTTTTTTCAAATGACATTCCTACTGGGGAGAAATT 
1081 TGCCTCCTGGGGACTCCCGGTTGTCTGTCTTGCTTTGCAGAGTTCCAGGACAGCCAGGGC 
1141 TACACAGAGAAACCCTGTCTCGAAAAAAAAAAAAAAAAAAGACTTTTCTCTGTCTAAATT 
1201 TAGTGACGCATGCGTGTATTCTGAAAGAAAGCACTGGGAGACCGTGAAGATGGTTTATAT 
  
cDNA 
 
1   atgccatgtgctcgggggagctggctggccaagctctcgatcgtggctcagcttattaat 
 
61  tttggggctttttgccacgggagacaaactcagccctggccggttcgcttcccagacccg 1F 
 
121 aggcaag│aacattttatcaagtccctgccagaataccacatagtgagtccagtccaagtc 
 
181 gatgctggtggccatgttctgtcctatggcctgcatcaccctgtcactagcagcaggaag 
 
241 aagagagctgcaggtggttctggggaccagctgtactacagaatttcgcatgaagaaaaa 
 
301 gacctgtttttcaatctgacggtcaactgggaatttctttccaacggctatgtcgtggag 
 
361 aagagatatgggaacctttcccatgttaagatggtggcttcctcaggccagccctgccat 
                                                              
421 ctcaggggcacagttctgcagcagggcaccacagtcgggatcgggacagcagctctcagt 
                                             
481 gcctgccaaggactg│actggatttttccatctaccacatggagactttttcatcgagcct 
 
541 gttaaaaagcatccactgaccgaggaagggtcctaccctcatgtcgtatacaggagacag 
 
601 agcatcagagctccagagacaaaggagcccatctgtggattaaagg│acagtcttgataac 
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661 tctgtgaaacaagagctacagcgggagaagtgggagaggaaaaccttgcggagcagaagc 2F 
 
721 ctctcccgacgttccataagcaaggagagatgggtggagaccctcgtggtggccgacacg 
 
781 aagacggtagagtaccatggaagcgagaacgtggagtcgtacatcctcaccatcatgaat 
                                             
841 atg│gtcactgggttgtttcatagcccaagcattggcaatctagtccacattgttgtggtt 1R 
 
901 cggctcattctacttgaagaagaggag│caaggattgaaaatagttcatcatgcagagaag 
 
961 acactgtccagtttctgcaagtggcagaagagcatcaatcccaagagtgacctcaaccct 
                                             
1021 gtccatcatgatgtggctgtccttatcaccag│aaaggacatctgtgctggtgtcaatcgc 
 
1081 ccttgtgagactctggggctgtcccaattgtcaggaatgtgccagcctcacaggagctgt 
 
1141 aacatcaatgaagactctggcctccccctggctttcaccattgcacatgaacttggtcac RT-F 
 
1201 ag│cttcggcatccagcatgatggaaaggaaaatgactgtgagcccgtgggcaggcaccca 
 
1261 tacatcatgtcccaacagattcagtacgacccaactccactaacatggtcgaaatgcagc RT-R 
 
1321 aaggagtacatcactcgcttcttgg│accgaggcagggggttctgtcttgatgatatcccc 
 
1381 agcaagaaaggcttgaagtccaacgtcattgctcctggagtaatttacgatgttcatcac 
 
1441 cagtgccagctccaatatggcccaaatgctacattctgccaggaagtggaaaatgtttgc 
 
1501 cagacactgtggtgctcggtgaaaggcttctgtcgctctaagctagatgctgctgcagac 3F 
 
1561 gggactcgttgcggtgagaagaagtggtgtatggctggaaagtgtatcacagtggggaag 2R 
                                              
1621 aaaccagagagcatccctggaggctggggacgctggtcaccctggtcacactgttctaga 
 
1681 acatgtggggcaggagctcagagcgcagagaggctctgcaacaacccaga│accaaaattt 
 
1741 ggagggaaatactgcaccggagaaagaaaacgctatcgcttatgcaatgtccacccctgc 
 
1801 cgctcagacactccaactttccggcagatgcagtgcagtgaatttgacacagtcccctac 
 
1861 aaaaaccaattctaccgctggttcccagtgtttaatgcag│cacatccttgtgagctgtac 
 
1921 tgcagacccatagatgaacagttttctgagagaatgctggaagctgtcattgatggcacc 
 
1981 ccatgcttcgaaggtggcaacagcagaaatgtctgtattaatggcatatgtaag│agggtt 
 
2041 ggctgtgactatgagattgattccaatgctacagaggatcgctgtggtgtgtgccttgga 
                           
2101 gatggctctgcctgccagacggtgaagaagctgtttagacagaaggaaggatctg│gttac 
 
2161 gttgacattggacttattcccaaaggtgcgagggatataagggtgatggaaatcaaggca 4F/3R 
 
2221 gctggcaatttcctggccattaggagtgaagatccggaaaaatactacctcaacggaggg 
                                                     
2281 ttcattatccagtggaatggaaactataaactggcagggaccgttttccagtatgacagg 
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2341 aaaggagatctggagaaacttatagctccaggccccaccaacgagtcagtgtggctccag│ 
 
2401 ctacttttccaggtgactaaccctggtatcaagtatgagtacacagtccggaaagatggc 
 
2461 cttgacaatgacgtggagaagttgctgtacttctggcaatttggccgctggacagaatgc 
 
2521 agtgtaacgtgtggaacag│gtatccgccggcaggctgctcattgtgtcaagaagggccac 
 
2581 ggtatagtgaaaacgaccttctgtaacccagaaacacagcccagcgtgagacagaagaag 
 
2641 tgccatgaaaaggactgtccacccag│gtggtgggcaggggagtgggaagcgtgttcaacg 
                                                    
2701 acatgtgggccctacggagaaaaaaagagaacggtgctgtgcatccagaccatgggctcg 
                                                             
2761 gatgaacaggctctccctgctacagactgccagcacctgctgaagcccaaagcactggtt 
                                            
2821 tcctgcaacagagatattctgtgtccatcagactggacagtaggcaactggagtgag│tgc 
 
2881 tctgtttcctgtggtggtggagtgcggattcgcagtgtcacatgtgccaagaaccttaat 
 
2941 gagccttgtgacaagacccggaaacccaacagtcgagctctgtgcggcctccagcagtgc 5F 
 
3001 ccatttagccgtagagttctgaaaccccataaagatatagctcccagtgggaaaaatcaa 
 
3061 tcgacagcagaacatgaccccttcaagcccatcccagcaccaacatccaggcccacgcca 
 
3121 ctgtccacacccacagtgcctgagtctatgagcacaagtactcccacaatcaacagcctt 4R 
 
3181 ggctccaccatagcatcccaagaagacgcaaatgggatgggatggcagaataattcaacc 
                                                
3241 caagctgaagagggctcccacttccctacttcttctggaagcacttcccaggtccccgtg 
 
3301 acttcctggtctttgagtatccaacctgatgatgagaatgtttccagctcagctataggt 
 
3361 cctacttcagagggtgacttttgggcaaccacaacaagtgattctggcttatcatctagc 
 
3421 gatgctatgacttggcaggtaactccattttatagcaccatgaccacagatccagaagtg 
                                              
3481 gagatacatagtggttcaggggaagacagtgaccagcctttgaacaaggacaaaagcaac 
 
3541 tctgtgatatggaataagatcggggtacctgaacatgatgctcccatggagacggatgca 
 
3601 gaactaccacttggacctccaccaacatcttatatgggggaagagccctcatggcctccc 
 
3661 ttcagtacaaaaatggaaggctcattacctgcctggtccttcaaaaatgagacacccagg 
 
3721 gatgatgggatgatcgctgaaaaatcaaggaagattccactccctcttgcaggagaccac 
                                                            
3781 catccagcaacctcagagaagttagaaaaccatgacaaattggcattgccaaatactaca 
           
3841 aatccaacccaaggctttgggcctgtcctgactgaagaagatgcctccaatctgattgcc 6F/5R 
 
3901 gaggggtttttgctaaatgcttctgattacaagcatcttatgaaggaccacagccctgca 
                                                          
3961 tactggattgttggaaactggagtaaa│tgctccactacctgtgggctgggggcctactgg 
                                                    
4021 aggagtgtggagtgcagctctggggtggacgctgactgcacaaccattcagaggccagac 
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4081 cctgctaagaagtgccacctccgcccctgtgctggctggcgagtgggaaactggagcaag│ 
 
4141 tgctcccgaaattgcagtggaggcttcaagattcgtgaggttcagtgcatggacagcctg 
 
4201 gaccaccaccggagcctgaggccgtttcactgtcaattcctagctggcgctcctcctcca 
 
4261 ctgagtatgagctgtaacctggagccttgtggagaatggcaagtggagccctggagccag│ 
 
4321 tgttctaggtcctgtggaggaggtgttcaggagagaggagtgtcttgtcctggaggcctc 
 
4381 tgtgactggacaaaaaggcctgcaaccactgtgccctgcaacagacacctttgctgtcac 
 
4441 tgggccactgggaactgggagctg│tgtaacacttcctgtggtggtggctctcagaaaaga 
 
4501 accattcattgcatcccctcagaaaacagtacaactgaagatcaagaccagtgcctctgt 
                                               
4561 gaccatcaagtcaaacccccagaattccaaacatgcaaccagcaagcctgcaggaagagt 
                                                                 
4621 gctg│atttaacttgcttgaaggacagactttcaatcagcttctgccagacactgaaatcc 
 
4681 atgaggaagtgctctgtgccatcagtgcgagcccagtgctgtctctcgtgtccacaggcg 6R 
 
4741 cccagcatccacacccagaggcaaagaaaacagcagttgctccaaaatcatgacatgctc 
 
4801 tag 
 
 
Last exon genomic DNA 
 
61 CAACCCAGGAGAGGAGGAGATGACGAATCAGCAGAGCCGATGCTCTCTAAACTAAGGAGA 
121 CGAAGCTGTATTGGTCCTGACAGGTGGAGGGAGGAGAGCCAGCAGTCATTCTGTGCATAC 7F 
181 AGCTATTTCTTCAGTGTGAAGAATCACTCTCCAGGTTAACGTAGTACCAACACTTCATCA 
241 TGCTCACAGATCCTGGGAGACAGGCATTTGTAAAGGGCATAAAAGGATGGAAAAATATCT 
301 ACTCCAATACGTTGGGCCTCTCAACTAAGAAGACTCAAAGACCATAGTCAAAGTTACTCA 
361 AAGACTCAGAGACTTGATCAAAGTCACTCAAATGTCTTGGGGATGGCACCATCTGAAGGC 
421 TCCTCTTGGATTCAAACTCTCACCTTCAGTCTTTAACCCAGGGCCTCTGAGGACGTGGGT 
481 TTCTTGTACAGTAGCATTCATATGGGTTCAAAATTCAACCTGCGTGGTCCTTTCTCCAGG 
541 TATCCGCCGGCAGGCTGCTCATTGTGTCAAGAAGGGCCACGGTATAGTGAAAACGACCTT 
601 CTGTAACCCAGAAACACAGCCCAGCGTGAGACAGAAGAAGTGCCATGAAAAGGACTGTCC 
661 ACCCAGGTAACCCTTGATAATATGAAGCTTGACCTTGTCTGGGTGTCACCTGGCCAGACA 
721 CCTAATTTAAGAGTGCTCCAAAGCACTATGGCTAGTCAATGCAGGAAAGCTCTGAGAGGT 
781 TTCTGTGACTGTGCTGTCACAAGACAAGCTGTGCCGATATTTTCTTTCCAGAGAGCAATT 
841 CTTCTTACAAAGTGGATACACTGTATGTTTTTATTTGCTAAGATTCAGTCTCAAACTGTT 
901 GAAGATAAAAATGTTCACAACATTCACCCAGAAACTGTTTAACTACCAGATGGTTTCGTT 7R 
961 CTCTGGGGCCATCTCTGCCGAATCTAGAACTTTCACTTACTCATACTCTGAATTGTCTGT 
1021 GTCCGTTCCTGACTTCAGGCTTTTCACAGGAGGACAATTAGAATGCAGGCGGGTGTCAGG 
1081 GCTGGGCTCATTATCAGGAGCTTTAGCCAGGACTTGGTCACTCAGCTACTGCACACAGAA 
1141 TTCTTCCTATCCCTGAAGCTTTATAGTGAACCTGGCATCTCATCATCTCTAGGATCTGAA 
1201 AGCAGCATGTTGGAACACAGTAAAGGATTTTGTTTTCTCCTCCAATGCTTAAGATGTGCT 
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Appendix 2: RNA purification manual 
 
Remember to use gloves under the whole procedure and change once in a while 
1: Mix 495 µl RLT-buffer with 5µl mercaptoethanol 
2: Clean the rotor-stator in detergent, 70 % ethanol and sterile water 
3: Transfer 10 - 20 µg tissue (approximately a half mouse spleen) to the RLT-buffer mix 
4: Disrupt the cells and homogenize cell mass with rotor-stator (approximately 15 - 90 s)  
– Tissue stored in RNAlater tend to be harder to disrupt and homogenize than 
fresh/thawed tissue 
5: Add 70 % ethanol in a 1:1 ration and mix gently with pipetting – Do not centrifuge 
6: Transfer max 700 µl sample, including precipitate, to an RNeasy spin column placed in 
a 2 ml collection tube  
– Centrifuge for 15 s at 8000 g  
– Discard flow-through 
7: Add 350 µl Buffer RW1 to the RNeasy spin column  
– Centrifuge for 15 s 8000 g  
– Discard the flow-through 
8: Add 10 µl DNase I stock solution to 70 µl Buffer RDD 
– Do not vortex DNaseI 
– Mix by gently inverting the tube and centrifuge briefly 
9: Add the DNase I incubation mix (80 µl) directly to the RNeasy spin column membrane
 – Place on the benchtop (20 – 30 °C) for 15 min 
10: Add 350 µl Buffer RW1 to the RNeasy spin column  
– Centrifuge for 15 s at 8000 g - Discard flow-through 
11: Add 500 µl Buffer RPE to the RNeasy spin column  
– Centrifuge for 15 s at 8000 g - Discard flow-through 
12: Add 500 µl Buffer RPE to the RNeasy spin column  
– Centrifuge for 2 min at 8000 g 
Note: After centrifugation, carefully remove the RNeasy spin column from the collection 
tube so that the column does not contact the flow-through. Otherwise, carryover of 
ethanol will occur. 
13: Place the RNeasy spin column in a new 2 ml collection 
– Centrifuge at full speed for 1 min 
14: Place the RNeasy spin column in a new 1.5 ml collection tube  
– Add 30 - 50 µl RNase-free water directly to the spin column membrane  
– Centrifuge for 1 min at 8000 g 
15: Add again 30 - 50 µl RNase-free water directly to the spin column membrane  
– Centrifuge for 1min at 8000 g 
(Qiagen, 2006). 
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Appendix 3: RT – PCR manual 
 
Reagent mix (on ice!). 
12.5µL Power SYBR Green PCR Master mix (2x) 
1 µL Forward primer (10µM) 
1 µL Reverse primer (10µM) 
0.5 µL cDNA 
10 µL Water 
 
In duplicate or triplicate for both the target gene and the reference (housekeeping-gene). 
Remember Blind without cDNA.  
Mix X x Master mix of the cDNA, H2O and Power SYBR Green PCR Mix, and split in 
two equal volumes, then add primers for reference and target gene. (Thereby equal 
amount of cDNA in all samples) Then add 25µL to each well in the MicroAmp Optical 
96-well reaction plate (frosted on the outside).   
Put Optical Adhesive covers PCR Compatible film over – used powder free gloves – the sealing 
needs to be tight – and without fingerprints, ect. Use the pad (brown) to seal.  
Put compression pad on top, gray side down – gives a tighter connection between the GeneAmp 
5700 and the plate.  
 
Start up of GeneAmp5700  
Turn on computer – hit Ctrl+Alt+Del  →   Username; Administrator          Password: 5700 
When desktop picture is on – turn on the GeneAmp5700 and the power supply. 
Then click on the “GeneAmp® 5700SDS” icon the desktop to start the software. 
Highlight “5700” in upper panel and “5700 Quantiation” in the lower panel, then click “OK”. 
You are now in the tray view. 
Define the plate – by highlight the wells with RT-PCR reaction and choose Unkn (unknown) in 
the drop down menu. If using standards – highlight the wells with standards and choose STD 
(standard) in the drop down menu. 
Important to highlight all well with mix – otherwise no data collection!!!! 
Highlight ALL wells with reaction mix then select the icon “P” and choose primers. If using 
several primers, add extra primers in “setup – Primer/probe setup” Choose “Add” then “OK”. 
Option; add the name on the content in each well by clicking on the well and enter the name in 
the name box. 
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Click on “Instrument” tab, choose “thermal profile” to enter PCR program. 95°C in 10 minutes to 
activate the AmpliTaq Gold polymerase, then (95°C in 15 sec, 60°C in 60 sec) x 40. 
 
Click √ at “dissociation protocol” to make a melting curve after the PCR. 
 
 
Save setup -otherwise no data collection!!! 
Place the PCR plate in the GeneAmp 5700 – and carefully tighten the heated lid. 
Click “Run” on the screen – check that the PC connects to the GeneAmp5700 and starts the PCR 
programme. Time remaining wills then starts to count down.  
 
Analyse. 
Choose the “results”tab. 
Highlight the wells with reaction mix – Click “analysis”, choose “analyse“.  
Set reference by choosing “Edit” then “Preference”.  
In first analysis, choose baseline start;  5 and  stop; 15. manual; 0.0000 
Then “analysis” and “analyse” every time any changes in the setup. 
In the “Amp plot” tab, choose “Rn vs Cycles” and “all” 
The plot can be either “linear” not “log” – change is by clicking on the Y-axis. 
The base line is the initial cycles of PCR in which there is little change in the fluorescence signal. 
Change the baseline in “Edit” then “Preference” so the blank gives Ct = 40 (see rapport tab) and 
are below the threshold. Start must be 5 or above – stop must be several cycles before the 
fluorescent PCR detection begins, normally between12-15. Remember to reanalyse…. 
The Ct (Threshold cycle) = The fraction cycle number at which the fluorescent passes the 
threshold. 
The threshold must be set in the exponential phase of the amplification curve. 
The Rn (Normalized reporter) = The ration of the fluorescent emission intensity of the reporter 
dye to the fluorescence emission intensity of the passive reference dye. (Normally not used). 
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Example on RT-PCR curves for the target and the reference gene (n=4).  
 
Standard curve (– test of primer efficiency before analysing – only once) 
For each primer – make a 10-fold dilution of a cDNA sample (1-104) and add reaction mix and 
primers as above. – For each 10-fold dilution the samples will be -3.3 cycles apart. More diluted 
samples will cross at a later Ct value. 
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y = 3,5675x + 18,418
R2 = 0,9976
y = 3,3435x + 20,739
R2 = 0,9981
15
20
25
30
35
0 0,5 1 1,5 2 2,5 3 3,5
Log dilution 
C
t
HPRT March 6 Lineær (HPRT ) Lineær (March 6)
 
The plot the Ct values against the dilution (the undiluted sample=0, 10xdiluted=1 ect.) 
Slope around 3.3 means 100% efficiency of the primers. If both primers have same efficiency, 
use the comparative Ct method for calculation. If not, make new primers or in calculate the 
efficiency. 
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Melting curve  (dissociation protocol) 
At the end of the amplification reaction the melting point of the PCR are measured, to test that it 
is only one amplified PCR product that the SYBR green is binding to.  
 
Dissociation curves for both the reference and target gene.  
 
Calculation, The comparative Ct method 
 
Calculate the mean and the standard deviation of the replicate samples.  
(Ct1 + Ct2 + Ct3 + Ct4 +Ct5)/5 = mean Ct ± 1 SD 
∆Ct= Ct target – Ct reference  
Example; 22.48-20.86= 1.28 
Standard deviation ∆Ct = (SDtarget2 + SDref2 ) ½      
Example; (0.392 + 0.352)½ = 0.52  
∆∆Ct= ∆Ct test sample -  ∆Ct calibrator sample 
 Example; ∆∆Ct= ∆CtCia32 – ∆Ct B10.RIII   (1.28 – 2.28 = -1.004)  
               ∆∆Ct= ∆CtDBA1 – ∆Ct B10.Q    (3.03 - 1.68 = 1.386) 
∆∆∆Ct = 2-∆∆Ct 
 Example; 2-∆∆Ct = 2-(-1.004) = 2.005 
      = 2-(1.386)  = 0.383 
Standard deviation ∆∆∆Ct = Standard deviation ∆Ct 
 Example; ∆∆Ct + SD = -1.004 + 0.521 =   -0.483  
  = 2- (-0.483) = 1.40 
                 ∆∆Ct - SD = -1.004 - 0.521 =   -1.525 
= 2- (-1.525) = 2.88 
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Example on results 
Sample March 6  
Ct mean 
(n=5) 
HPRT (ref) 
Ct mean 
(n=5) 
∆Ct 
(March6-
HPRT) 
∆∆Ct ∆∆∆Ct 
Cia 32 22.48±0.39 20.86±0.35 1.28 ±0.521 -1.004  2.005 (1.40-
2.88) 
B10.RIII 22.04±0.15 19.76±0.24 2.28 ±0.285   
DBA1 24.91±0.31 21.84±0.27 3.06 ±0.473 1.386 0.383 (0.29-
0.51) 
B10.Q 22.78±0.36 21.11±0.20 1.68 ±0.411   
The Cia32 has up regulated the expression of March 6 RNA compared to the B10.RIII 
The DBA1 has down regulated the expression to 0.383 of the March 6 compared to the 
B10.Q.  
 
  
